Status:
COMPLETED
Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
18+ years
Brief Summary
A questionnaire composed of items addressing psychological, emotional and social aspects of GERD is developed for Chinese population. We plan to conduct a validation study on this novel disease-specif...
Eligibility Criteria
Inclusion
- Patients presenting with 1 attack of heartburn and/or acid regurgitation per week as chief complaint in recent 6 months
Exclusion
- Patients with
- GERD as GI involvement of systemic disease e.g. scleroderma, SLE, thyrotoxicosis, chronic intestinal pseudo-obstruction
- Cause of esophagitis other than GERD e.g. drug induced, infection, nasogastric tube injury
- Previous gastrointestinal or hepatobiliary surgery (including cholecystectomy)
- Organic pathology of upper GI tract that may present as reflux / dyspeptic symptom e.g. peptic ulcer, gastric cancer, gastric outlet obstruction
- Presence of alarm symptom that does not suggest functional GI disorder
- Use of NSAID in recent 4 weeks (Low dose aspirin \< 300 mg is allowed)
- Pregnant woman or lactating female
- Illiterate patient (who cannot administer questionnaire)
- Known hypersensitivity to PPI
Key Trial Info
Start Date :
September 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT00165022
Start Date
September 1 2003
End Date
October 1 2006
Last Update
March 31 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endoscopy Centre, Prince of Wales Hospital
Hong Kong, China